Related Experiment Video
Updated: Mar 22, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
LDL Cholesterol Goal Attainment in Hypercholesterolemia: CEPHEUS Indonesian Survey
Muhammad Munawar1, Beny Hartono2, Sodiqur Rifqi3
1Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia; ; Binawaluya Cardiac Center, Jakarta;
Insights
Indonesian patients with hypercholesterolemia often do not reach their LDL cholesterol goals despite lipid-lowering therapy. This highlights a significant gap in cardiovascular disease risk management for this population.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Hypercholesterolemia management remains suboptimal, with many patients failing to achieve target cholesterol levels.
- Lipid-lowering therapy effectiveness in Indonesian hypercholesterolemic patients requires further investigation.
Purpose of the Study:
- To assess the achievement of lipid-lowering treatment goals in Indonesian patients with hypercholesterolemia.
- To identify factors influencing goal attainment in this patient group.
Main Methods:
- A survey of 979 hypercholesterolemic patients (≥18 years) on lipid-lowering treatment for ≥3 months was conducted.
- Data collected included lipid concentrations, demographics, and clinical information, analyzed using 2004 NCEP-ATP III criteria.
Main Results:
- Only 31.3% of Indonesian patients achieved their LDL cholesterol goals, significantly lower than the Asian average (49.1%).
- Goal attainment was lowest (<12.1%) for patients targeting LDL-C <70 mg/dL and lower in those with metabolic syndrome (28%).
- Achievement was inversely related to cardiovascular risk and baseline LDL-C; 65.1% of patients underestimated the impact of missed doses.
Conclusions:
- A high percentage of Indonesian hypercholesterolemic patients on lipid-lowering drugs do not meet recommended LDL-C levels.
- These patients remain at elevated risk for cardiovascular disease due to inadequate cholesterol management.
Background:
Several studies have shown that lipid-lowering therapy to address hypercholesterolemia is generally inadequate because the target cholesterol goal is not achieved. Our study reviews the cholesterol goal attainment among patients receiving lipid lowering therapy in Indonesian hypercholesterolemic patients.
Methods:
This surveywas part of the Pan-Asian CEPHEUS (CEntralized Pan-Asian survey on tHE Under-treatment of hypercholeSterolemia) study, involving hypercholesterolemic patients ≥ 18 years of age, who were on lipid- lowering treatment for ≥ 3 months. Lipid concentrations were measured, demographic and other clinically relevant information were collected. Definitions and criteria set by the updated 2004 National Cholesterol Education Program - Adult Treatment Program III was applied.
Results:
In this survey, 149 physicians enrolled 979 patients, of whom only 834 were included in the final analysis. The mean age was 56.5 years, 53.5% male, and 82.3% were on statin monotherapy. The LDL-C goal attainment rate amongst Indonesians (31.3%)was belowthat of the overall Asian rate (49.1%). The lowest attainment (12.1%)was found in patients with a therapeutic target < 70 mg/dL. Additionally, the goal attainment rate in patients with metabolic syndrome (28%) was significantly lower than in patients without metabolic syndrome (37.5%, p = 0.006). Goal attainment was inversely related to cardiovascular risk and baseline LDL-C (p < 0.001). It was also noted that approximately 65.1% of patients believed he/she could miss a dosage without affecting his/her blood cholesterol concentration.
Conclusions:
High proportions of Indonesian hypercholesterolemic patients on lipid-lowering drug are not at the recommended LDL-C levels, and remain at risk for cardiovascular disease.
Key Words:
Cardiovascular disease; Dyslipidemia; Hypercholesterolemia; Indonesian; LDL cholesterol.
Related Concept Videos
Lipids: Dietary Sources and Requirements
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Cholesterol: Significance and Regulation
Considering cholesterol and...

